SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-201280
Filing Date
2019-07-24
Accepted
2019-07-24 16:34:02
Documents
5
Effectiveness Date
2019-07-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A d764722ddefa14a.htm DEFA14A 17511
2 GRAPHIC g764722im01.jpg GRAPHIC 129276
3 GRAPHIC g764722im02.jpg GRAPHIC 223207
4 GRAPHIC g764722im03.jpg GRAPHIC 56573
5 GRAPHIC g764722im04.jpg GRAPHIC 10336
  Complete submission text file 0001193125-19-201280.txt   584284
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Filer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36819 | Film No.: 19971292
SIC: 2836 Biological Products, (No Diagnostic Substances)